Verona Pharma to raise £3 million

AIM-quoted drug discovery company Verona Pharma aims to raise approximately £3 million before expenses with a placing at 13p. The money will be used to develop the company’s leading product, the RPL554 drug, as well as two other products

Nick Britton

Nick Britton

Nick was the Managing Editor for when it was owned by Vitesse Media, before moving on to become Head of Investment Group and Editor at What Investment and thence to Head of Intermediary...

Related Topics

Early Stage Funding